Diabetes Advocacy Alliance Diabetes Advocacy Alliance Diabetes Advocacy Alliance

Latest News

New ADA infograph on the “Staggering Cost of Diabetes” is now available.

Click Here for More Info

On July 28, 2015, the CDC issued 2014 National Diabetes Report Card.

Click Here for More Info

DAA focuses on needs of seniors with diabetes and prediabetes entering Medicare, in poster presentation at the HHS Healthy Aging Summit, July 27-28, 2015, in Washington, DC.

Click Here for More Info

Member Profile

Novo Nordisk Inc.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit www.novonordisk.com.

Click Here to Read More

The Diabetes Advocacy AllianceTM is working to increase awareness of, and action on, the diabetes epidemic among legislators and policymakers.  We are a diverse group of patient advocacy organizations, professional societies, trade associations and corporations, sharing a common goal to defeat diabetes.  Explore our site to learn more about what's on the front burner in our communications with Capitol Hill and the Administration. The Diabetes Advocacy Alliance™ is working to increase awareness of, and action on, the diabetes epidemic among legislators and policymakers. We are a diverse group of patient advocacy organizations, professional societies, trade associations and corporations, sharing a common goal to defeat diabetes. Explore our site to learn more about what's on the front burner in our communications with Capitol Hill and the Administration.

DAA Priorities for 2015

The Diabetes Advocacy Alliance (DAA) has public policy and legislative priorities in three areas: Prevention of type 2 diabetes; improved screening and detection of those adults with prediabetes and undiagnosed diabetes; and improved care for people whose diabetes has been diagnosed. A summary of DAA and DAA member priorities in diabetes is presented in this document: Advocacy Priorities in 2015.